Researchers in Japan and the United States have developed a new technology to increase visibility of cancer cells to the immune system using CRISPR. The findings were led by Koichi Kobayashi, professor at Hokkaido University and Texas A&M Health Center, and Paul de Figueiredo, Bond LSC principal investigator and NEXTGEN Precision Health endowed professor at […]
Read more of this post
No comments:
Post a Comment